| 000 | 01191 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517113848.0 | ||
| 264 | 0 | _c20180507 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1945-7197 | ||
| 024 | 7 |
_a10.1210/jc.2016-2457 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMakras, Polyzois | |
| 245 | 0 | 0 |
_aLetter to the Editor: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _c09 2016 |
||
| 300 |
_aL89-90 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aBone Density |
| 650 | 0 | 4 | _aBone Density Conservation Agents |
| 650 | 0 | 4 | _aDenosumab |
| 650 | 0 | 4 | _aDiphosphonates |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImidazoles |
| 650 | 0 | 4 | _aMinerals |
| 650 | 0 | 4 | _aZoledronic Acid |
| 700 | 1 | _aPolyzos, Stergios A | |
| 700 | 1 | _aAnastasilakis, Athanasios D | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 101 _gno. 9 _gp. L89-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2016-2457 _zAvailable from publisher's website |
| 999 |
_c26394302 _d26394302 |
||